$OWLT
Owlet, Inc. Stock $owlt

$owlt Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000162828024010048 Filed on March 08, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$14.75M	$21.00M	$54.01M
YoY Change	37.39%	75.03%	-21.95%
Cost Of Revenue	$8.203M	$11.13M	$31.42M
YoY Change	24.61%	29.44%	-31.54%
Gross Profit	$6.547M	$9.872M	$22.59M
YoY Change	57.65%	190.35%	-3.06%
Gross Profit Margin	44.39%	47.0%	41.82%
Selling, General & Admin	$9.946M	$10.67M	$40.87M
YoY Change	-18.6%	-45.3%	-48.91%
% of Gross Profit	151.92%	108.04%	180.94%
Research & Development	$2.347M	$2.288M	$10.35M
YoY Change	-18.79%	-49.16%	-62.91%
% of Gross Profit	35.85%	23.18%	45.82%
Depreciation & Amortization	$109.0K	$136.0K	$842.0K
YoY Change	-62.8%	-61.8%	-40.62%
% of Gross Profit	1.66%	1.38%	3.73%
Operating Expenses	$12.29M	$12.95M	$51.22M
YoY Change	-18.64%	-46.25%	-52.53%
Operating Profit	-$5.746M	-$3.082M	-$28.63M
YoY Change	-47.55%	-85.11%	-66.16%
Interest Expense	$161.0K	-$193.0K	$3.191M
YoY Change	-94.27%	-35.67%	-390.09%
% of Operating Profit
Other Income/Expense, Net	$9.020M	-$3.646M	-$4.259M
YoY Change	-1090.12%	-343.07%	-166.55%
Pretax Income	$3.274M	-$6.921M	-$32.89M
YoY Change	-127.59%	-64.51%	-58.52%
Income Tax	$0.00	$5.000K	$10.00K
% Of Pretax Income	0.0%
Net Earnings	$3.274M	-$8.219M	-$32.90M
YoY Change	-127.59%	-57.85%	-58.51%
Net Earnings / Revenue	22.2%	-39.13%	-60.92%
Basic Earnings Per Share	$0.15		-$4.53
Diluted Earnings Per Share	-$0.51	-$0.97	-$4.53
COMMON SHARES
Basic Shares Outstanding	8.964M shares	8.569M shares	8.276M shares
Diluted Shares Outstanding	9.618M shares		8.276M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.40M	$16.56M	$16.56M
YoY Change	-25.71%	47.83%	47.83%
Cash & Equivalents	$18.40M	$16.56M	$16.56M
Short-Term Investments
Other Short-Term Assets	$2.288M	$2.921M	$2.921M
YoY Change	-53.84%	-47.84%	-47.84%
Inventory	$7.738M	$6.493M	$6.493M
Prepaid Expenses
Receivables	$11.60M	$13.97M	$13.97M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$40.02M	$39.94M	$39.94M
YoY Change	-33.15%	-22.14%	-22.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$284.0K	$377.0K	$1.314M
YoY Change	-65.95%	-88.91%	-61.35%
Goodwill
YoY Change
Intangibles	$2.209M	$2.210M
YoY Change	-2.69%	-3.03%
Long-Term Investments
YoY Change
Other Assets	$733.0K	$655.0K	$655.0K
YoY Change	-29.18%	-40.45%	-40.45%
Total Long-Term Assets	$3.807M	$4.179M	$4.179M
YoY Change	-37.25%	-38.54%	-38.54%
TOTAL ASSETS
Total Short-Term Assets	$40.02M	$39.94M	$39.94M
Total Long-Term Assets	$3.807M	$4.179M	$4.179M
Total Assets	$43.83M	$44.12M	$44.12M
YoY Change	-33.52%	-24.06%	-24.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.06M	$13.68M	$13.68M
YoY Change	-47.91%	-55.0%	-55.0%
Accrued Expenses	$11.00M	$15.05M	$15.05M
YoY Change	-21.62%	-24.75%	-24.75%
Deferred Revenue	$1.144M	$1.166M
YoY Change	9.79%	1.57%
Short-Term Debt	$7.212M	$9.250M	$9.250M
YoY Change		96.81%	96.81%
Long-Term Debt Due	$4.032M	$5.944M	$5.944M
YoY Change	-15.96%	-42.85%	-42.85%
Total Short-Term Liabilities	$39.46M	$45.09M	$45.09M
YoY Change	-22.21%	-32.3%	-32.3%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Other Long-Term Liabilities	$705.0K	$906.0K	$28.71M
YoY Change	-64.87%	-56.86%	1267.1%
Total Long-Term Liabilities	$705.0K	$906.0K	$28.71M
YoY Change	-87.2%	-56.86%	1267.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$39.46M	$45.09M	$45.09M
Total Long-Term Liabilities	$705.0K	$906.0K	$28.71M
Total Liabilities	$65.62M	$73.80M	$73.80M
YoY Change	-19.87%	7.42%	7.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$252.4M	-$255.7M
YoY Change	7.57%	14.77%
Common Stock	$1.000K	$1.000K
YoY Change	-91.67%	-91.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$32.93M	-$37.53M	-$29.68M
YoY Change
Total Liabilities & Shareholders Equity	$43.83M	$44.12M	$44.12M
YoY Change	-33.52%	-24.06%	-24.06%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$3.274M	-$8.219M	-$32.90M
YoY Change	-127.59%	-57.85%	-58.51%
Depreciation, Depletion And Amortization	$109.0K	$136.0K	$842.0K
YoY Change	-62.8%	-61.8%	-40.62%
Cash From Operating Activities	-$3.339M	-$1.576M	-$23.53M
YoY Change	-64.38%	-83.96%	-71.09%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$29.00K	$16.00K
YoY Change	-100.0%	-82.1%	-97.48%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$54.00K	-$29.00K	-$59.00K
YoY Change	575.0%	-82.1%	-96.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$1.500M		$3.500M
YoY Change	0.0%		-41.67%
Cash From Financing Activities	$5.233M	2.997M	$28.91M
YoY Change	-77.16%	-253.22%	-3392.94%
NET CHANGE
Cash From Operating Activities	-$3.339M	-1.576M	-$23.53M
Cash From Investing Activities	-$54.00K	-29.00K	-$59.00K
Cash From Financing Activities	$5.233M	2.997M	$28.91M
Net Change In Cash	$1.840M	1.392M	$5.326M
YoY Change	-86.4%	-111.66%	-106.35%
FREE CASH FLOW
Cash From Operating Activities	-$3.339M	-$1.576M	-$23.53M
Capital Expenditures	$0.00	$29.00K	$16.00K
Free Cash Flow	-$3.339M	-$1.605M	-$23.54M
YoY Change	-64.4%	-83.93%	-71.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2022	owlt	Other Income Expense Net OtherIncomeExpenseNet	79000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5312000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32891000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-79307000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-32901000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-79336000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55191000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8797456	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8797456	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-32901000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1235000	usd
CY2022	owlt	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	2584000	usd
CY2023Q4	owlt	Long Term Debt Future Aggregate Maturity Total LongTermDebtFutureAggregateMaturityTotal	5944000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001816708
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	owlt	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	Consolidated Statements of Operations and Comprehensive Loss
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	25800000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8964338	shares
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16557000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11231000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13973000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15958000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6493000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	18515000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2921000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5558000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	39944000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	51262000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	377000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1108000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	937000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2260000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2210000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2279000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	655000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	1195000	usd
CY2023Q4	us-gaap	Assets Assets	44123000	usd
CY2022Q4	us-gaap	Assets Assets	58104000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13679000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	30432000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15051000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19984000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1166000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1148000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9250000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4685000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5944000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10353000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45090000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	66602000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1162000	usd
CY2023Q4	owlt	Common Stock Warrant Liability CommonStockWarrantLiability	27781000	usd
CY2022Q4	owlt	Common Stock Warrant Liability CommonStockWarrantLiability	724000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	906000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	251000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	73799000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	68739000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7855000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	107142857	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	107142857	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8242009	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8242009	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	218127000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	212122000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-255659000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-222758000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-37531000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10635000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44123000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58104000	usd
CY2023	us-gaap	Gross Profit GrossProfit	22587000	usd
CY2022	us-gaap	Gross Profit GrossProfit	23313000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27343000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41547000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13527000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38489000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10349000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27896000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	51219000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	107932000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-28632000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-84619000	usd
CY2023	us-gaap	Interest Expense InterestExpense	3191000	usd
CY2022	us-gaap	Interest Expense InterestExpense	1104000	usd
CY2023	owlt	Change In Fair Value Of Common Stock Warrantliability ChangeInFairValueOfCommonStockWarrantliability	-924000	usd
CY2022	owlt	Change In Fair Value Of Common Stock Warrantliability ChangeInFairValueOfCommonStockWarrantliability	6337000	usd
CY2023	owlt	Other Income Expense Net OtherIncomeExpenseNet	-144000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4259000	usd
CY2023	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4591000	usd
CY2022	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-37492000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37492000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-79336000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-79336000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.53
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.53
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-9.98
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.98
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8276481	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8276481	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7950757	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7950757	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	259000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	359000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12892000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-79336000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10635000	usd
CY2023	owlt	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	30000	shares
CY2023	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	3867000	usd
CY2023	owlt	Temporary Equity Issuance Costs TemporaryEquityIssuanceCosts	253000	usd
CY2023	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4591000	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4591000	usd
CY2023	owlt	Temporary Equity Conversion Shares TemporaryEquityConversionShares	-1372	shares
CY2023	owlt	Temporary Equity Conversion Value TemporaryEquityConversionValue	350000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	350000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	43000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	55000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	215000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9933000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-32901000	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	28628	shares
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7855000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-37531000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-79336000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	842000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1418000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	9933000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	12856000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1020000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3014000	usd
CY2023	owlt	Change In Fair Value Of Common Stock Warrantliability ChangeInFairValueOfCommonStockWarrantliability	-924000	usd
CY2022	owlt	Change In Fair Value Of Common Stock Warrantliability ChangeInFairValueOfCommonStockWarrantliability	6337000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1369000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1253000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-109000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-953000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-965000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8504000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3177000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6226000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12118000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1181000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-19503000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10720000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1580000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1022000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23527000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-81380000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	636000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	43000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	929000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-59000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1565000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1513000	usd
CY2023	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	28487000	usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	99988000	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	44530000	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	96832000	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	40026000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	500000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3500000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	269000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	618000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28912000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-878000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5326000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-83823000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11231000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95054000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16557000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11231000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1876000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1075000	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	350000	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	107142857	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key management estimates include those related to revenue recognition (including standalone selling price, usage period of hardware products sold, sales incentives, product returns and implied post contract support and service), allowances for doubtful accounts, write-downs for obsolete or slow-moving inventory, useful lives for property and equipment, impairment assessments for long-lived tangible and intangible assets, warranty obligations, valuation allowances for net deferred income tax assets, uncertain tax positions, and valuation of warrants and stock-based compensation.</span></div>
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-255659000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23527000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-81380000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16557000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	30000000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	1448000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	377000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1108000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2210000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	280000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2279000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	206000	usd
CY2023Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	1873000	usd
CY2022Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	1873000	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
CY2023	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	41000	usd
CY2023	owlt	Product Warranty Period ProductWarrantyPeriod	P1Y
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	6670000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	26226000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3760000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4165000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3383000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3057000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	403000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3014000	usd
CY2022	owlt	Accounts Receivable Allowance For Doubtful Accounts Charges To Revenue AccountsReceivableAllowanceForDoubtfulAccountsChargesToRevenue	63000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	341000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3013000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3013000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1020000	usd
CY2023	owlt	Accounts Receivable Allowance For Doubtful Accounts Charges To Revenue AccountsReceivableAllowanceForDoubtfulAccountsChargesToRevenue	29000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	682000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3322000	usd
CY2023Q4	owlt	Accrued Sales Return Current AccruedSalesReturnCurrent	2919000	usd
CY2022Q4	owlt	Accrued Sales Return Current AccruedSalesReturnCurrent	6756000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	712000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	661000	usd
CY2023	owlt	Provision For Warranties Issued During The Period ProvisionForWarrantiesIssuedDuringThePeriod	574000	usd
CY2022	owlt	Provision For Warranties Issued During The Period ProvisionForWarrantiesIssuedDuringThePeriod	526000	usd
CY2023	owlt	Settlements Of Warranty Claims During The Period SettlementsOfWarrantyClaimsDuringThePeriod	504000	usd
CY2022	owlt	Settlements Of Warranty Claims During The Period SettlementsOfWarrantyClaimsDuringThePeriod	475000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	782000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	712000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	937000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2260000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1169000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2105000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1162000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1191000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3267000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y8M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2022	owlt	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	1050000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1537000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1492000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	2257000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1231000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	45000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	530000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1197000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	22000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1219000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	28000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1191000	usd
CY2023Q4	owlt	Lessee Operating Lease Number Of Sublease Arrangements LesseeOperatingLeaseNumberOfSubleaseArrangements	3	arrangement
CY2023Q4	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P1Y
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	726000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	1292000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	975000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1386000	usd
CY2023	owlt	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	1918000	usd
CY2023	owlt	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	2002000	usd
CY2022	owlt	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	2433000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1302000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1386000	usd
CY2023	owlt	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	1169000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	5944000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	10353000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5944000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10353000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2023Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	9288000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	9250000	usd
CY2023Q4	owlt	Long Term Debt Future Aggregate Maturity Year One LongTermDebtFutureAggregateMaturityYearOne	5944000	usd
CY2023Q1	owlt	Related Party Transaction Monthly Interest Payment To Related Party RelatedPartyTransactionMonthlyInterestPaymentToRelatedParty	3000000	usd
CY2023Q1	owlt	Related Party Transaction Monthly Interest Payment To Related Party Payment Period RelatedPartyTransactionMonthlyInterestPaymentToRelatedPartyPaymentPeriod	P36M
CY2023Q1	owlt	Related Party Transaction Monthly Interest Payment To Related Party Payment Period RelatedPartyTransactionMonthlyInterestPaymentToRelatedPartyPaymentPeriod	P36M
CY2021Q4	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	2	claim
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	598155	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.35
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	739762	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.15
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	136326	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.21
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5707	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	25.62
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	18054	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.12
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	58337	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.42
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	253010	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	30.26
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	79732	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	52.46
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	249	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.06
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	9245	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	60.76
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	463168	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.03
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	598155	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.35
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	440324	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	15.19
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	524974	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	20.34
CY2023Q3	owlt	Share Based Payment Arrangement Plan Modification Number Of Options Modified ShareBasedPaymentArrangementPlanModificationNumberOfOptionsModified	136326	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	29000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1416000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	763000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M3D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	746000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y7M17D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1489000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M25D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1489000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y6M7D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1153000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3958000	usd
CY2023	owlt	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	171000	usd
CY2022	owlt	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	91000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.26
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.97
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	463168	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	763000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	16.03
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y9M3D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	10080000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	5239000	usd
CY2023	owlt	Employee Stock Purchase Plan Average Purchase Price Of Shares Purchased EmployeeStockPurchasePlanAveragePurchasePriceOfSharesPurchased	4.96
CY2022	owlt	Employee Stock Purchase Plan Average Purchase Price Of Shares Purchased EmployeeStockPurchasePlanAveragePurchasePriceOfSharesPurchased	23.80
CY2023	owlt	Aggregate Intrinsic Value Of Shares Purchased Under Employee Stock Purchase Plan AggregateIntrinsicValueOfSharesPurchasedUnderEmployeeStockPurchasePlan	38000	usd
CY2022	owlt	Aggregate Intrinsic Value Of Shares Purchased Under Employee Stock Purchase Plan AggregateIntrinsicValueOfSharesPurchasedUnderEmployeeStockPurchasePlan	64000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9933000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12856000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1070000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	36000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1513000	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	253000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1292856	shares
CY2023	owlt	Class Of Warrant Or Right Warrants Issued During Period ClassOfWarrantOrRightWarrantsIssuedDuringPeriod	7882426	shares
CY2023	owlt	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9175282	shares
CY2023Q4	owlt	Common Stock Shares Subject To Vesting CommonStockSharesSubjectToVesting	200536	shares
CY2023	owlt	Number Of Trading Days NumberOfTradingDays	20	d
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	16489000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	27781000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	11070000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	724000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6907000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-16654000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-636000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2737000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4487000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	19994000	usd
CY2023	owlt	Effective Income Tax Rate Reconciliation Warrant Expense Benefit Amount EffectiveIncomeTaxRateReconciliationWarrantExpenseBenefitAmount	194000	usd
CY2022	owlt	Effective Income Tax Rate Reconciliation Warrant Expense Benefit Amount EffectiveIncomeTaxRateReconciliationWarrantExpenseBenefitAmount	-1331000	usd
CY2023	owlt	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	375000	usd
CY2022	owlt	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	0	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2101000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	895000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	396000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-138000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2509000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2734000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1719000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2452000	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	1823000	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	1051000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	43726000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38042000	usd
CY2023Q4	owlt	Deferred Tax Assets174 Capitalization DeferredTaxAssets174Capitalization	4195000	usd
CY2022Q4	owlt	Deferred Tax Assets174 Capitalization DeferredTaxAssets174Capitalization	5379000	usd
CY2023Q4	owlt	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	289000	usd
CY2022Q4	owlt	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	800000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1153000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	802000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	55414000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	51260000	usd
CY2023Q4	owlt	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	228000	usd
CY2022Q4	owlt	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	554000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	23000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	30000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	251000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	584000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55163000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	50676000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55163000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4487000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-32901000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-79336000	usd
CY2023	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4591000	usd
CY2022	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-37492000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37492000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-79336000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-79336000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8276481	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8276481	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7950757	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7950757	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.53
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.53
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.98
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-9.98
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15369919	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2488807	shares
CY2023Q4	owlt	Common Stock Shares Subject To Vesting CommonStockSharesSubjectToVesting	200536	shares
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54010000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	69202000	usd
CY2023Q4	owlt	Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1314000	usd
CY2022Q4	owlt	Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	3368000	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	238

Files In Submission

Name	View Source	Status
0001628280-24-010048-index-headers.html	Edgar Link	pending
0001628280-24-010048-index.html	Edgar Link	pending
0001628280-24-010048.txt	Edgar Link	pending
0001628280-24-010048-xbrl.zip	Edgar Link	pending
ex-211owletincsubsidiaries2.htm	Edgar Link	pending
ex-311owletinc302certifica.htm	Edgar Link	pending
ex-312owletinc302certifica.htm	Edgar Link	pending
ex-321owletinc906certifica.htm	Edgar Link	pending
ex-322owletinc906certifica.htm	Edgar Link	pending
ex1017-fourthamendmenttoth.htm	Edgar Link	pending
ex31-secondarcertificateof.htm	Edgar Link	pending
exhibit971form12x31x23xcla.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fy2310kpwcconsent.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
owlt-20231231.htm	Edgar Link	pending
owlt-20231231.xsd	Edgar Link	pending
owlt-20231231_g1.jpg	Edgar Link	pending
owlt-descriptionofsecuriti.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
owlt-20231231_def.xml	Edgar Link	unprocessable
owlt-20231231_lab.xml	Edgar Link	unprocessable
owlt-20231231_pre.xml	Edgar Link	unprocessable
owlt-20231231_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
owlt-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OWLT
Owlet, Inc. Stock $owlt

2024 Q1 Form 10-K Financial Statement

#000162828024010048 Filed on March 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OWLT Owlet, Inc. Stock $owlt

2024 Q1 Form 10-K Financial Statement

#000162828024010048 Filed on March 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OWLT
Owlet, Inc. Stock $owlt